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WHAT THIS PAPER ADDS
 Up until recently, carotid endarterectomy in UK was not done sufﬁciently early following symptoms of cerebral ischaemia. This
study suggests that the early management of patients with symptoms of cerebral ischaemia at a one-stop stroke prevention or TIA
clinic with Duplex imaging could promote rapid surgery. It also supports the current initiative to focus stroke services in the UK
within specialist centres.a r t i c l e i n f o
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Introduction: Carotid endarterectomy (CEA) should be performed within two weeks of symptoms for
patients with carotid stenosis >50%. Whether these standards are being achieved and causes of delay
between symptoms and CEA were investigated.
Design: An analysis of prospectively collected multi-centre data.
Materials: Consecutive data for patients undergoing CEA between January-2006 and September-2010
were collected. Asymptomatic patients and those with no details on the timing of cerebral symptoms
were excluded.
Methods: ‘Delay’ from symptom to CEA was deﬁned as more than two weeks and ‘prolonged-delay’ more
than eight weeks. Univariable and multivariable analyses were used to identify factors associated with
these delays.
Results: Of 2147 patients with symptoms of cerebral ischaemia, 1522(70.9%) experienced ‘delay’ and
920(42.9%) experienced ‘prolonged delay’. Patients with ischaemic heart disease were more likely to
experience ‘delay’ (OR ¼ 1.56; 95% CI 1.11e2.19, p ¼ 0.011), whereas patients with stroke (OR ¼ 0.77; 95%
CI 0.63e0.94, p ¼ 0.011) and those treated at hospitals with a stroke-prevention clinic (OR ¼ 0.57; 95%CI
0.46e0.71, p < 0.001) were less likely to experience ‘delay’. Patients treated after the publication of
National Institute for Health and Clinical Excellence (NICE) guidelines were less likely to experience
‘prolonged delay’ (OR ¼ 0.77; 95%CI 0.65e0.91, p ¼ 0.003) but not ‘delay’.
Conclusion: Few patients achieved CEA within two weeks of symptoms. Introducing stroke-prevention
clinics with one-stop carotid imaging appears important.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.; fax: þ44 (0) 161 291 5854.
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Carotid endarterectomy (CEA) reduces the risk of stroke in
patients with recently symptomatic severe carotid artery stenosis
and, to a lesser extent, patients with asymptomatic carotid sten-
osis.1e4 The main beneﬁt of surgery, the reduction in stroke risk,
is greatest if surgery is performed early following symptomsd by Elsevier Ltd. All rights reserved.
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Symptomatic Carotid Endarterectomy (NASCET) and European
Carotid Surgery (ECST) trials demonstrating that surgery delayed
beyond 12 weeks from the onset of symptoms had equivalent
efﬁcacy to that for asymptomatic disease.5
The National Institute for Health and Clinical Excellence (NICE)
issued guidelines in July 20086 which recommended that stable
patients following acute non-disabling stroke or transient ischae-
mic attack (TIA) who have symptomatic carotid stenosis of 50e99%
(NASCET), or 70e99% (ECST) criteria, should:
i. be assessed and referred for CEA within one week of onset of
symptoms.
ii. undergo surgery within two weeks of symptoms.
Although the NICE guidelines and others7 have raised awareness
of the importance of offering early CEA to symptomatic patients,
unacceptable delays to surgery have still been demonstrated in the
UK.8 The aim of this study was to investigate the causes of delay in
carotid surgery in the North West of England.Materials and Methods
This was a prospective multi-centre study conducted on behalf of
the Vascular Governance NorthWest (VGNW) programme. VGNW is
a peer-led clinical governance programme that currently audits the
results of 55 vascular surgeons who perform CEA at 21 hospitals in
the North West of England and Wales. Data were collected prospec-
tively using apurpose-designeddata-entry formonconsecutive CEAs
performed between January 2006 and October 2010. Data were
mainly supplied by the operating surgeons with missing data
completed where possible from patient medical records. Data
collected included patient demographics, date of symptom onset,
referral details, the indication for surgery, medical history, pre-
operative medications and pre-operative investigations.
All data was entered into a central Microsoft Access database
held at the University Hospital of SouthManchester (UHSM). To test
the completeness of data, the numbers of operations carried out at
participating hospitals were validated against Hospital Episode
Statistics (HES) and cross checked with discharge summaries.
Follow-up data was obtained by contacting the clinical team
responsible for each patient following discharge.
The primary outcome measure for the study was delay from
symptoms to CEA of over twoweeks. Secondary outcomemeasures
were delay from symptoms to CEA of over eight weeks (prolonged
delay) and post-operative stroke or mortality. Mortality was
deﬁned as death within 30-days following CEA regardless of cause
and strokewas as deﬁned by the contributing surgeon. All variables
missing for more than 15 percent of patients were excluded from
the analysis. Categorical variables were coded as 1 if they were
present; otherwise they were coded as 0, meaning that if a condi-
tion or ﬁnding was not recorded or mentioned in the patient’s
record, or the test had not been performed, the condition was
assumed to be absent. For continuous variables the sample median
was substituted for missing values.Figure 1. Percentage of patients waiting longer than two or eight weeks from symp-
toms to CEA in the North West of England by year of procedure.Statistical Analysis
The c2 test or univariable logistic regression was used for
statistical analysis of categorical or ordinal variables which are
shown as percentages. Standard statistical tests were used to
calculate odds ratios and 95% conﬁdence intervals (CI). A multi-
variable logistic regression analysis was undertaken using the
forward stepwise technique, to identify risk factors for delay andprolonged delay from symptoms to CEA. All analysis was performed
using SPSS 16.0 (SPSS Inc., Chicago IL).
Results
Over the study period, a total of 2976 CEAs were performed. CEA
was performed for symptomatic carotid artery stenosis in 2573
(86.5%) patients. Information on the interval between symptoms
and the surgery was available for 2147(83.4%) of the symptomatic
patients with this group representing the ﬁnal cohort for all
subsequent analyses.
Patient characteristics
Themedian age of the patients was 72 years (range 39e100) and
1465 (68.4%) were men. TIA, stroke and amaurousis fugax were the
presenting symptoms for 1065(49.6%), 632 (29.4%) and 450 (21.0%)
patients respectively. Ipsilateral carotid stenosiswas 70e99% for the
majority (1804, 84.0%) of patients and 50e69% in a further 625
(13.7%). The ipsilateral stenosiswas<50% for 34 (1.6%) patientswith
15 (0.7%) patients having complete ipsilateral occlusion. Carotid
imaging was by Duplex ultrasound initially in 2028 (94.5%) patients
with conﬁrmatory imaging, usually by magnetic resonance angi-
ography (MRA)or CTangiographyperformed in 412 (19.2%) patients.
Most patients were referred by a hospital physician (1883, 87.7%).
Symptom to carotid surgery delay
The majority of patients (1522, 70.9%) waited longer than two
weeks between initial symptoms and CEA with the median delay
being 5e7 weeks. A total of 920 (42.9%) patients underwent CEA
more than eight weeks from the symptoms that precipitated
referral. The percentage of patients who underwent CEA more than
twoweeks ormore thaneightweeks after symptoms for eachyear of
the study is shown in Fig. 1. The publication of NICE guidelines has
been associated with a reduction in the number of patients waiting
for longer than twoweeks (68.4%vs. 73.7%,OR0.7795%CI 0.64e0.93,
p ¼ 0.007), and the number of patients waiting longer than eight
weeks (39.5% vs. 46.6%, OR 0.75 95%CI 0.63e0.89, p ¼ 0.001).
Univariable analysis for causes of delay from symptoms to CEA
Factors associated with a delay from symptoms to CEA of more
than two week are shown in Table 1. Patients with a history of
Table 1












Age (years) <65 23.9 69.3 Ref. 43.0 Ref.
65e74 39.6 72.4 1.16(0.92e1.48) 0.217 44.2 1.05(0.84e1.31) 0.668
75 36.4 70.3 1.05(0.83e1.34) 0.681 41.3 0.93(0.75e1.17) 0.546
Gender Male 68.4 70.3 Ref. 42.8 Ref.
Female 31.6 72.2 1.10(0.90e1.34) 0.376 42.9 1.00(0.83e1.20) 0.997
Diabetes No 83.7 70.8 Ref. 42.9 Ref.
Yes 16.3 71.5 1.04(0.81e1.34) 0.780 42.5 0.98(0.78e1.24) 0.868
Ischaemic heart disease No 90.0 70.1 Ref. 41.9 Ref.
Yes 10.0 78.1 1.53(1.09e2.14) 0.014 51.2 1.45(1.09e1.92) 0.010
Indication for surgery Other 70.6 72.7 Ref. 44.7 Ref.
Stroke 29.4 66.6 0.75(0.61e0.92) 0.005 38.4 0.77(0.64e0.94) 0.008
Ipsilateral stenosis <70% 15.3 69.5 Ref. 41.8 Ref.
70% 84.7 70.9 1.08(0.84e1.40) 0.551 42.9 1.05(0.83e1.34) 0.667
Contralateral stenosis <70% 76.6 70.1 Ref. 41.9 Ref.
70% 23.4 73.4 1.17(0.94e1.47) 0.164 45.9 1.18(0.96e1.44) 0.112
Referral source GP 12.3 76.5 Ref. 50.0 Ref.
Physician 87.7 70.1 0.72(0.53e0.97) 0.032 41.8 0.72(0.56e0.93) 0.012
Hospital stroke-prevention
clinic
No 76.3 73.8 Ref. 45.5 Ref.
Yes 23.7 61.6 0.57(0.46e0.70) <0.001 34.4 0.63(0.51e0.78) <0.001
Initial imaging modality MRA/CT 5.5 63.0 Ref. 43.3 Ref.
Duplex ultrasound 94.5 71.4 0.68(0.47e1.01) 0.053 35.3 0.71(0.49e1.05) 0.088
NICE guidelines Pre 47.6 73.7 Ref. 46.6 Ref.
Post 52.4 68.4 0.77(0.64e0.93) 0.007 39.5 0.75(0.63e0.89) 0.001
Other ¼ TIA or amaurosis fugax; MRA ¼ magnetic resonance angiography; CT ¼ CT angiography, p values calculated using univariable logistic regression; ref ¼ reference
group; GP ¼ general practitioner; CEA ¼ carotid endarterectomy; NICE ¼ National Institute for Health and Clinical Excellence. Bold ¼ signiﬁcant at p < 0.05.
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than two weeks from initial symptoms to CEA. Patients that were
referred for surgery by a hospital physician, presented with
a stroke, or were treated at a hospital with a dedicated
stroke-prevention clinic were less likely to have CEA more than
two weeks from initial symptoms. Factors associated with a delay
from symptoms to CEA of more than eight weeks were the same
as for a delay of more than two weeks and are also shown in
Table 1.
Multivariable analysis
Factors associated with a delay from initial symptoms to CEA of
more than two weeks on multivariable analysis are shown in
Table 2. Patients with a history of ischaemic heart disease were
found to be more likely to have a delay from symptoms to CEA of
more than twoweeks. Patients who presented with a stroke or who
underwent CEA at a hospital with a dedicated stroke-prevention
clinic were less likely to undergo CEA more than two weeks after
the symptoms that caused referral.
Factors found to be associated with a less than eight week
delay from symptoms to CEA on multivariable analysis are
shown in Table 3 and included; presentation with stroke,
referral by a hospital physician and CEA performed at a hospital
with a dedicated stroke-prevention clinic. CEA after the intro-
duction of NICE guidelines was also found to be a factor asso-
ciated with a delay from initial symptoms to CEA of less than
eight weeks.Table 2
Risk factors for delay from symptoms to CEA of >2 weeks; logistic regression
analysis (n ¼ 2147).
Odds ratio (95% CI) p value
Stroke as indication for surgery 0.77(0.63e0.94) 0.011
Ischaemic heart disease 1.56(1.11e2.19) 0.011
Hospital with stroke-prevention clinic 0.57(0.46e0.71) <0.001
CEA ¼ carotid endarterectomy.Outcomes following CEA
Post-operative stroke occurred in 32 (1.5%) patients with 21 of
these strokes within 24 hours and 11 over the next 30 days. The
overall 30-day mortality rate in the cohort was 0.6% (12 deaths)
giving a combined stroke and death rate of 2.0%. Patients who
underwent CEAwithin twoweeks of symptoms had a stroke rate of
2.2% compared to 1.2% (OR 1.92 95%CI 0.95e3.87, p ¼ 0.066) for
patients who were delayed for more than two weeks. The stroke
rates in patients who underwent CEA within eight weeks of
symptoms ormore than eight weeks from symptomswere 1.4% and
1.6% respectively (OR 0.85 95%CI 0.42e1.71, p ¼ 0.643). There was
also a non-signiﬁcant reduction in stroke rate since the publication
of the NICE guidelines from 1.8% to 1.2% (OR 0.70 95%CI 0.35e1.42,
p ¼ 0.324).Discussion
Despite the introduction of NICE guidelines6 recommending
that patients with symptoms of symptomatic carotid stenosis
should have CEAwithin two weeks; this was not achieved for most
patients in the NorthWest of England. These ﬁndings are consistent
with the ﬁrst National UKCEA audit.8 However, since the publica-
tion of the NICE guidelines, the proportion of patients waiting for
more than two weeks or eight weeks from symptoms to CEA has
reduced. This improvement was signiﬁcant for two week delay onTable 3
Risk factors for delay from symptoms to CEA of >8 weeks; logistic regression
analsyis (n ¼ 2147).
Odds ratio (95% CI) p value
Stroke as indication for surgery 0.82(0.68e0.99) 0.043
Post NICE guidelines 0.77(0.65e0.91) 0.003
Referral by hospital physician 0.77 (0.59e1.00) 0.047
Hospital with stroke-prevention clinic 0.64(0.52e0.79) <0.001
CEA ¼ carotid endarterectomy; NICE ¼ National Institute for Health and Clinical
Excellence.
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analysis. The fact that the improvement demonstrated is not more
signiﬁcant is unsurprising given that the NICE guidelines, although
published in 2008, were only widely implemented in the UK during
2010e2011. Other drivers for change have however been imple-
mented during the period of this study and a reduction in CEA
waiting times was demonstrated in round two of the UKCEA audit.9
The data used for this study was collected prospectively and
validated locally. It has not been externally validated which is
a limitation of this study. Contribution to VGNW is voluntary and it is
likely that not all CEAs performed during the study period have been
included. As with any registry study, data quality and completeness
were a limitation although any data ﬁelds with more than 15%
missing datawere excluded from the analysis.We have conducted an
appropriate statistical analysis of our available data but as with any
observational study it is impossible to eliminate other confounding
factors that may have contributed to the conclusions.
The post-operative 30-day stroke rate, 30-day death rate and
combined stroke and death rate in this study is similar to the
recent UKCEA study9 but lower than the major randomised clinical
trials and other earlier registries, perhaps reﬂecting continued
improvements in care.1,2,10e16 However, the patients in this study
were followed up by the teams who undertook the surgery, and it is
recognised that higher post-operative stroke rates are often repor-
ted when follow-up is by a stroke physician. The stroke rate in this
study was non-signiﬁcantly higher for patients operated on within
two weeks of symptoms. This has previously been demonstrated in
a systematic review17 and could possibly be explained in this study
by the observation that stroke was a more common indication for
surgery in the group operated on within two weeks of symptoms.
The stroke rate was also found to have fallen non-signiﬁcantly in
this study following the publication of the NICE guidelines.
Reducing waiting times from symptoms to surgery is imperative
if CEA is to be effective.5 Delays are common in the literature with
studies from the late 1990s onwards in England,11,18 Sweden,12
Canada,13 and Scotland,14 reporting median delays between
symptoms of cerebral ischaemia and CEA ranging from two to ﬁve
months. In the ECST, the median delay from randomization to CEA
in the 29 UK centres (1086 patients) in the 1980s and early 1990s
was more than two months, meaning a delay from symptom to
surgery of much more than this.1 The median randomisation to
surgery delay in ECST was also more than a month in Denmark,
Finland, Italy, Norway, Portugal, and Sweden, and no country
achieved amedian delay of less than twoweeks. In the NASCETonly
45% of patients underwent CEA within one month of random-
isation, with nearly 20% operated on aftermore than four months.19
A recent study from a Swedish tertiary referral centre found only
11% of patients underwent CEA within two weeks of symptoms.20
The majority of patients in the literature have therefore under-
gone CEA after the critical time interval when the beneﬁts of
surgery most clearly outweigh best medical treatment.5 In addition
to reduced clinical effectiveness; the cost effectiveness of such
delayed surgery is clearly poor.
This study has identiﬁed a number of risk factors for delayed
CEA, addressing these would be important if CEA services are to
continue to improve. Patients with a history of ischaemic heart
disease were signiﬁcantly more likely to wait longer than two
weeks from symptoms to CEA. As it is likely that these patients
will undergo additional pre-operative investigations or may
require coronary interventions for their ischaemic heart disease
prior to CEA, this may be difﬁcult to address. In this study, patients
who presented with a stroke were more likely to undergo CEA
within two weeks. Reducing delays from symptom to CEA for
patients with TIA or amaurosis fugax is important and potentially
achievable.One of the key ﬁndings in this study is that hospitals having
stroke-prevention clinics were more likely to achieve CEA within
two weeks of symptoms and were less likely to have patients
waiting more than eight weeks. This suggests that rapid access to
stroke prevention clinics with one-stop carotid imaging is
essential for reducing delay from symptoms to CEA in the future.
It is also a powerful argument supporting the current initiative to
focus stroke services in the UK within specialist centres. However
as suggested by the UKCEA study,9 stroke services are probably
underutilised and strategies should also focus on utilising stroke
services to capacity as well as making it easier for smaller
hospitals to access them. It has also been suggested that
the urgent assessment of patients with symptoms of cerebral
ischaemia in a specialised clinic can reduce stroke risk and
healthcare costs.21,22
Patients who were referred for CEA directly by their GP were
more likely to wait longer than both two and eight weeks for CEA
although this was only signiﬁcant on multivariable analysis for
eight week delay. This ﬁnding of lower delay for patients referred
by hospital physicians was also demonstrated in the UKCEA study.9
This could potentially be addressed by direct access stroke
prevention or TIA clinics. Alternatively fast track carotid imaging by
Duplex, such as that introduced in Gloucester halving symptom to
CEA intervals to a median of under seven weeks, may be an
approach suitable for other geographical areas.23
As patients treated at hospitals with stroke-prevention clinics
and patients who were referred by hospital physicians were less
likely to be delayed, it is likely that a regional protocol deﬁning the
early management of patients with symptoms of cerebral
ischaemia, and greater use of stroke prevention clinics, would
improve access to rapid CEA.21 This protocol would involve suitable
patients being seen urgently in open access stroke prevention or
TIA clinics with “one stop” Duplex imaging available immediately.
Patients who are then considered ﬁt for surgery with >50% carotid
stenosis should be referred directly to vascular surgeons who have
pre-booked operating capacity for urgent CEAs. Implementing such
protocols will involve signiﬁcant efforts from clinicians, managers
and commissioners but will be of important clinical beneﬁt.
Appendix. VGNW participants
Arrowe Park Hospital:MGreaney, S Blair, R Chandrasekar, C Chan,
A Chaudhuri, L Williams, V Kappadath. Blackburn Royal Inﬁrmary:
S Hardy, R Salaman. Blackpool Victoria Hospital : V Perricone,
H Osman. Burnley General Hospital: H Al-Khaffaf, A Rahi. Countess of
Chester: L de Cossart, P Edwards, S Dimitri. M Hamish. Glan
Clwyd Hospital: O Klimach, Y Rouhani. Leigh Inﬁrmary: J Mosley.
Leighton Hospital: M Hanafy. Manchester Royal Inﬁrmary:JV Smyth,
F Serracino-Inglott. North Manchester District General Hospital:
G Williams, M Madan, W Tait. Royal Bolton Hospital: G Ferguson,
M Onwudike.Royal Lancaster Inﬁrmary: J Abraham, P Wilson,
M Bukhari, J Calvey, M Tomlinson. Royal Liverpool University Hospital
: J Brennan, V Rao, R Fisher. Royal Oldham Hospital: T Oshodi, M
Hadﬁeld. Royal Preston Hospital: G Thomson, A Egun. University
Hospital of South Manchester: C McCollum, M Baguneid, M Welch.
Southport District General Hospital: D Jones. Tameside District General
Hospital: A Woodyer, C Pratap, L Wolowczyk. University Hospital
Aintree: J Joseph, F Torella. Warrington District General Hospital:
P Moody, T Nicholas, P Wake, D Olojugba.WrexhamMaelor Hospital:
U Kirkpatrick, A da Silva.
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